Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melan...
Q2 2026
Aug 4, 2026
Q1 2026
May 5, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Nov 4, 2025